Mechanisms Underlying Impaired Diabetic Wound Healing

NCT00777712 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2025-06-03

No results posted yet for this study

Summary

The overall aim of this research is to utilize wound derived inflammatory cells from diabetic versus non diabetic human chronic wounds to understand mechanisms that are responsible for disregulated inflammation in individuals with diabetes. Biology of normal (peripheral blood derived cells) versus wound derived cells will also be studied.

Conditions

Interventions

OTHER

Blood draw

Blood will be drawn from subjects once and VAC sponge will be collected (which is normally discarded material per standard of care).

Sponsors & Collaborators

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Sashwati Roy, Ph.D. · University of Pittsburgh

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-01
Primary Completion
2029-12-31
Completion
2030-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00777712 on ClinicalTrials.gov